Biodexa Pharmaceuticals Plc (BDRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 184,845.64 |
| Enterprise Value | -8.27M |
| P/E Ratio | -0 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.01 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.35 |
| Return On Equity | -0.56 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -184,857 |
| EBITDA | -8.08M |
| Net Income | -6.24M |
| Diluted EPS | -400 |
| Total Cash | 8.52M |
| Total Cash/Share | 94.31 |
| Total Debt | 60,892 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 2.03 |
| Book Value Per Share | 126.04 |
| 52-Week Change | -96.01 |
| 52-Week High | 59.4 |
| 52-Week Low | 1.02 |
| Moving Average 50 Days | 2.08 |
| Moving Average 200 Days | 8.07 |
| Average Volume | 186,944 |
| Shares Outstanding | 746,113 |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | April 06, 2026 |